The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Oral GS-5806 Activity in a Respiratory Syncytial Virus Challenge Study
Open accessAbstract
BACKGROUND: Respiratory syncytial virus (RSV) is a common cause of infant hospitalizations and is increasingly recognized as a cause of considerable morbidity and mortality. No accepted antiviral treatment exists. METHODS: We conducted a double-blind, placebo-controlled study of GS-5806, an oral RSV-entry inhibitor, in healthy adults who received a clinical challenge strain of RSV intranasally. Participants were monitored for 12 days. At the time of a positive test for RSV infection or 5 days after inoculation, whichever occurred first, participants were randomly assigned to receive GS-5806 or placebo in one of seven sequential cohorts. Cohorts 1 to 4 received a first dose of 50 mg of GS-5806 and then 25 mg daily for the next 4 days, cohort 5 received a first dose of 50 mg and then 25 mg daily for the next 2 days, cohort 6 received one 100-mg dose, and cohort 7 received a first dose of 10 mg and then 5 mg daily for the next 4 days. Dose selection for cohorts 5, 6, and 7 occurred after an interim analysis of data for cohorts 1 to 4. The primary end point was the area under the curve (AUC) for the viral load, which was assessed after administration of the first dose through the 12th day after inoculation. Secondary end points were mucus weight and symptom scores. RESULTS: Among the 54 participants in cohorts 1 to 4 who were infected with RSV, active treatment was associated with a lower viral load (adjusted mean, 250.7 vs. 757.7 log10 plaque-forming-unit equivalents [PFUe] × hours per milliliter; P<0.001), lower total mucus weight (mean, 6.9 g vs. 15.1 g; P=0.03), and a lower AUC for the change from baseline in symptom scores (adjusted mean, -20.2 vs. 204.9 × hours; P=0.005). The results were similar in cohorts 5, 6, and 7. Adverse events, including low neutrophil counts and increased levels of alanine aminotransferase, were more common among participants receiving GS-5806. CONCLUSIONS: Treatment with GS-5806 reduced the viral load and the severity of clinical disease in a challenge study of healthy adults. (Funded by Gilead Sciences; ClinicalTrials.gov number, NCT01756482.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ventre, K., & Randolph, A. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000181.pub3 · Cited by 312
RetractedMortality Associated With Influenza and Respiratory Syncytial Virus in the United States
Thompson, W. W., Shay, D. K., Weintraub, E., Brammer, L., Cox, N., Anderson, L. J., & Fukuda, K. (2003) · JAMA · doi:10.1001/jama.289.2.179 · Cited by 3,673
Nair, H., Nokes, D. J., Gessner, B. D., Dherani, M., Madhi, S. A., Singleton, R. J., O'Brien, K. L., Roca, A., Wright, P. F., Bruce, N., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60206-1 · Cited by 2,773
The Burden of Respiratory Syncytial Virus Infection in Young Children
Hall, C. B., Weinberg, G. A., Iwane, M. K., Blumkin, A. K., Edwards, K. M., Staat, M. A., Auinger, P., Griffin, M. R., Poehling, K. A., Erdman, D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0804877 · Cited by 2,246
Respiratory Syncytial Virus Infection in Elderly and High-Risk Adults
Falsey, A. R., Hennessey, P. A., Formica, M. A., Cox, C., & Walsh, E. E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043951 · Cited by 2,226
Bronchiolitis-Associated Hospitalizations Among US Children, 1980-1996
Shay, D. K. (1999) · JAMA · doi:10.1001/jama.282.15.1440 · Cited by 1,385
Diagnosis and Management of Bronchiolitis
Bronchiolitis, S. O. D. A. M. O. (2006) · Pediatrics · doi:10.1542/peds.2006-2223 · Cited by 1,062
Treanor, J. J., Hayden, F. G., Vrooman, P. S., Barbarash, R., Bettis, R., Riff, D., Singh, S., Kinnersley, N., Ward, P., Mills, R. G., et al. (2000) · JAMA · doi:10.1001/jama.283.8.1016 · Cited by 1,014
Hayden, F. G., Osterhaus, A. D. M. E., Treanor, J. J., Fleming, D. M., Aoki, F. Y., Nicholson, K. G., Bohnen, A. M., Hirst, H. M., Keene, O., & Wightman, K. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709253371302 · Cited by 762
Oral oseltamivir treatment of influenza in children
WHITLEY, R. J., HAYDEN, F. G., REISINGER, K. S., YOUNG, N., DUTKOWSKI, R., IPE, D., MILLS, R. G., & WARD, P. (2001) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200102000-00002 · Cited by 711
Self-citationRates of hospitalization for respiratory syncytial virus infection among children in Medicaid
Boyce, T. G., Mellen, B. G., Mitchel, E. F., Wright, P. F., & Griffin, M. R. (2000) · The Journal of Pediatrics · doi:10.1067/mpd.2000.110531 · Cited by 688
Respiratory Syncytial Virus and Recurrent Wheeze in Healthy Preterm Infants
Blanken, M. O., Rovers, M. M., Molenaar, J. M., Winkler-Seinstra, P. L., Meijer, A., Kimpen, J. L. L., & Bont, L. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211917 · Cited by 671
DeVincenzo, J., Lambkin-Williams, R., Wilkinson, T., Cehelsky, J., Nochur, S., Walsh, E., Meyers, R., Gollob, J., & Vaishnaw, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912186107 · Cited by 442
Self-citationRecent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000
Leader, S., & Kohlhase, K. (2003) · The Journal of Pediatrics · doi:10.1067/s0022-3476(03)00510-9 · Cited by 426
Widmer, K., Zhu, Y., Williams, J. V., Griffin, M. R., Edwards, K. M., & Talbot, H. K. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis309 · Cited by 364
High Morbidity and Mortality in Adults Hospitalized for Respiratory Syncytial Virus Infections
Lee, N., Lui, G. C. Y., Wong, K. T., Li, T. C. M., Tse, E. C. M., Chan, J. Y. C., Yu, J., Wong, S. S. M., Choi, K. W., Wong, R. Y. K., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit471 · Cited by 360
Stockman, L. J., Curns, A. T., Anderson, L. J., & Fischer-Langley, G. (2012) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31822e68e6 · Cited by 352
Viral Load Drives Disease in Humans Experimentally Infected with Respiratory Syncytial Virus
DeVincenzo, J. P., Wilkinson, T., Vaishnaw, A., Cehelsky, J., Meyers, R., Nochur, S., Harrison, L., Meeking, P., Mann, A., Moane, E., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201002-0221oc · Cited by 330
Self-citation(2009) · PEDIATRICS · doi:10.1542/peds.2009-2345 · Cited by 326
Safety and Efficacy of the Neuraminidase Inhibitor GG167 in Experimental Human Influenza
Hayden, F. G. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530280047035 · Cited by 291
Respiratory Syncytial Virus Load Predicts Disease Severity in Previously Healthy Infants
DeVincenzo, J. P., El Saleeby, C. M., & Bush, A. J. (2005) · The Journal of Infectious Diseases · doi:10.1086/430008 · Cited by 233
Self-citationMonoclonal antibody for reducing the risk of respiratory syncytial virus infection in children
Andabaka, T., Nickerson, J. W., Rojas-Reyes, M. X., Rueda, J. D., Bacic Vrca, V., & Barsic, B. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006602.pub4 · Cited by 212
Houben, M. L., Coenjaerts, F. E. J., Rossen, J. W. A., Belderbos, M. E., Hofland, R. W., Kimpen, J. L. L., & Bont, L. (2010) · Journal of Medical Virology · doi:10.1002/jmv.21771 · Cited by 159
Viral Shedding and Immune Responses to Respiratory Syncytial Virus Infection in Older Adults
Walsh, E. E., Peterson, D. R., Kalkanoglu, A. E., Lee, F. E.-H., & Falsey, A. R. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit038 · Cited by 156
Buckingham, S. C., BUSH, A. J., & DeVincenzo, J. P. (2000) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200002000-00006 · Cited by 140
Self-citationWaghmare, A., Campbell, A. P., Xie, H., Seo, S., Kuypers, J. M., Leisenring, W. M., Jerome, K. R., Englund, J. A., & Boeckh, M. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit639 · Cited by 133
Oral Oseltamivir in Human Experimental Influenza B Infection
Hayden, F. G., Jennings, L., Robson, R. A., Schiff, G. M., Jackson, H. C., Rana, B., McClelland, G., Ipe, D., Roberts, N. A., & Ward, P. (2000) · Antiviral Therapy · doi:10.1177/135965350000500305 · Cited by 96
Risk Factors for Respiratory Failure Associated with Respiratory Syncytial Virus Infection in Adults
Duncan, C. B., Walsh, E. E., Peterson, D. R., Lee, F. E.-H., & Falsey, A. R. (2009) · The Journal of Infectious Diseases · doi:10.1086/605948 · Cited by 88
Bagga, B., Woods, C. W., Veldman, T., Gilbert, A., Mann, A., Balaratnam, G., Lambkin‐Williams, R., OXFORD, J. S., McClain, M. T., Wilkinson, T. M. A., et al. (2013) · Antiviral Therapy · doi:10.3851/imp2629 · Cited by 66
Self-citation
Cited by
Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment
Griffiths, C., Drews, S. J., & Marchant, D. J. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00010-16 · Cited by 586
Respiratory syncytial virus entry and how to block it
Battles, M. B., & McLellan, J. S. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0149-x · Cited by 402
Respiratory syncytial virus infection in adults
Nam, H. H., & Ison, M. G. (2019) · BMJ · doi:10.1136/bmj.l5021 · Cited by 332
Mazur, N. I., Martinón-Torres, F., Baraldi, E., Fauroux, B., Greenough, A., Heikkinen, T., Manzoni, P., Mejias, A., Nair, H., Papadopoulos, N. G., et al. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00255-6 · Cited by 296
Huang, H.-S., Tsai, C.-L., Chang, J., Hsu, T.-C., Lin, S., & Lee, C.-C. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.11.018 · Cited by 277
Self-citation
Metadata
- Authors
- DeVincenzo, J. P., Whitley, R. J., Mackman, R. L., Scaglioni-Weinlich, C., Harrison, L., Farrell, E., McBride, S., Lambkin-Williams, R., Jordan, R., Xin, Y., Ramanathan, S., O’Riordan, T., Lewis, S. A., Li, X., Toback, S. L., Lin, S.-L., & Chien, J. W.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2014-08-21
- Volume
- 371
- Issue
- 8
- Pages
- 711-722
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2028941141
- Cited by
- 339
- References
- 29
- FWCI
- 33.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.